New Therapeutic Options for Type 2 Diabetes Mellitus and Their Impact Against Ischemic Heart Disease

Type 2 diabetes mellitus (T2DM) greatly increases risk for cardiovascular disease, including ischemic heart disease and myocardial infarction. With the completion of several cardiovascular outcomes trials (CVOTs) for new glucose-lowering therapies, including the sodium-glucose cotransporter-2 (SGLT2...

Descripción completa

Detalles Bibliográficos
Autores principales: Almutairi, Malak, Chan, Jordan S. F., Ussher, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271769/
https://www.ncbi.nlm.nih.gov/pubmed/35832485
http://dx.doi.org/10.3389/fphys.2022.904626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271769/
https://www.ncbi.nlm.nih.gov/pubmed/35832485
http://dx.doi.org/10.3389/fphys.2022.904626

Ejemplares similares